Smith and Nephew News

In this role, Arnold is responsible for setting the global product strategy for KCI.

Smith & Nephew , the global medical technology business, today announces preliminary independent data showing that patients using the PICO Negative Pressure Wound Therapy System experienced reduced healing times, a higher degree of conformability, increased comfort and greater ease to use over conventional NPWT.

Smith & Nephew , the global medical technology business, today announces the closing of the acquisition of privately-held Kalypto Medical, Inc., by its group company Smith & Nephew, Inc., adding to Smith & Nephew's own Negative Pressure Wound Therapy innovation pipeline and intellectual property portfolio.

Medical device company Smith & Nephew has launched a spinoff in Durham, N.C., called Bioventus.

Headquartered in Durham, N.C., Bioventus is Smith & Nephew's former Biologics Division/Clinical Therapies business that generates about 250 million dollars in revenue annually on a worldwide basis.

Smith & Nephew last week reported its net profit grew 3 percent in the first quarter, helped by an increase in revenue, profit and trading margins in the company's Advanced Surgical Devices and Advanced Wound Management divisions.

Shares of Smith & Nephew rise sharply as its first quarter trading profit, boosted by knee replacements and wound care, of $252 million compared to $241 million year-to-year becomes known.

For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements.

Smith & Nephew Plc, Europe's biggest maker of artificial hips and knees, said first-quarter earnings rose 5 percent, driven by growth in wound care.